Centro Nacional De Investigaciones Cardiovasculares Carlos III (F.s.p.)

Centro Nacional De Investigaciones Cardiovasculares Carlos III (F.s.p.) is a foreign-owned, non-profit organization and foundation registered in SAM.gov since April 2008, with current registration valid through June 2025. While primarily operating as a Spanish research institution, the entity has established connections with U.S. federal grant mechanisms, specifically participating in biomedical research sub-awards. As a research-focused foundation, Centro Nacional De Investigaciones Cardiovasculares Carlos III likely specializes in cardiovascular research and innovative medical therapies, leveraging its expertise in scientific investigation and medical technology development.

The organization has consistently been involved in sub-grant awards through the University of South Florida, focusing specifically on a research project titled "PEPTIBODIES AS NOVEL THERAPIES IN ATRIAL FIBRILLATION". These sub-grant awards have been consistently awarded over multiple years, with documented sub-awards on March 12, 2025, July 29, 2024, and June 29, 2023. The repeated nature of these awards suggests a sustained research initiative exploring innovative therapeutic approaches for atrial fibrillation, likely involving advanced peptide-based medical interventions. While the specific federal funding agency is not directly identified in the available data, the sub-awards indicate a collaborative research effort between the Spanish research center and the University of South Florida, potentially supported by a U.S. federal health research grant program such as those administered by the National Institutes of Health (NIH).